LS Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,515
Closed -$1.23M 426
2021
Q1
$1.23M Sell
2,515
-373
-13% -$187K 0.07% 213
2020
Q4
$1.44M Sell
2,888
-82
-3% -$36.7K 0.08% 220
2020
Q3
$1.17M Sell
2,970
-2,593
-47% -$959K 0.07% 238
2020
Q2
$1.84M Buy
5,563
+2,597
+88% +$752K 0.11% 168
2020
Q1
$718K Sell
2,966
-455
-13% -$119K 0.05% 278
2019
Q4
$893K Buy
3,421
+218
+7% +$57.4K 0.05% 325
2019
Q3
$871K Sell
3,203
-70
-2% -$19.5K 0.05% 307
2019
Q2
$901K Sell
3,273
-151
-4% -$37.2K 0.05% 297
2019
Q1
$766K Buy
3,424
+45
+1% +$9.29K 0.05% 325
2018
Q4
$629K Sell
3,379
-186
-5% -$38.1K 0.04% 346
2018
Q3
$890K Sell
3,565
-410
-10% -$99.5K 0.05% 314
2018
Q2
$866K Sell
3,975
-181
-4% -$37.3K 0.05% 317
2018
Q1
$795K Buy
4,156
+72
+2% +$13.3K 0.05% 337
2017
Q4
$639K Sell
4,084
-762
-16% -$120K 0.04% 410
2017
Q3
$754K Buy
4,846
+368
+8% +$58.2K 0.04% 343
2017
Q2
$723K Buy
4,478
+128
+3% +$20.8K 0.04% 362
2017
Q1
$673K Sell
4,350
-3,916
-47% -$540K 0.04% 350
2016
Q4
$969K Buy
8,266
+192
+2% +$21.9K 0.07% 245
2016
Q3
$910K Sell
8,074
-551
-6% -$58.1K 0.07% 242
2016
Q2
$801K Buy
8,625
+5,059
+142% +$434K 0.06% 283
2016
Q1
$279K Buy
3,566
+188
+6% +$13.5K 0.02% 569
2015
Q4
$246K Sell
3,378
-36
-1% -$2.57K 0.02% 587
2015
Q3
$253K Sell
3,414
-157
-4% -$11.2K 0.02% 570
2015
Q2
$229K Buy
3,571
+3,547
+14,779% +$246K 0.02% 595
2015
Q1
$2K Hold
24
﹤0.01% 901
2014
Q4
$2K Hold
24
﹤0.01% 922
2014
Q3
$1K Buy
+24
New +$1.52K ﹤0.01% 953

Other funds holding IDXX

LS Investment Advisors's IDXX Position: Q2 2021 in Review

LS Investment Advisors sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 2,515 shares — an estimated $1.23M sold.

LS Investment Advisors first reported a position in IDXX in Q3 2014 and held it in 27 quarters. The position peaked at $1.84M in Q2 2020. 1,034 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

  • LS Investment Advisors reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 2,515 Idexx Laboratories shares in Q2 2021, an estimated $1.23M.
  • LS Investment Advisors first reported a position in Idexx Laboratories in Q3 2014 and held it in 27 quarters.
  • LS Investment Advisors's Idexx Laboratories position peaked at $1.84M in Q2 2020.
  • 1,034 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.